Chemoinformaics analysis of Tricyclo[3.2.1.02,7]oct-3-ene, 2,3,4,5-tetramethyl-
Molecular Weight | 162.276 | nRot | 0 |
Heavy Atom Molecular Weight | 144.132 | nRig | 10 |
Exact Molecular Weight | 162.141 | nRing | 4 |
Solubility: LogS | -4.596 | nHRing | 0 |
Solubility: LogP | 4.037 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 32.0423 |
nHD | 0 | BPOL | 18.0577 |
QED | 0.479 |
Synth | 5.514 |
Natural Product Likeliness | 1.184 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.022 |
Pgp-sub | 0 |
HIA | 0.008 |
CACO-2 | -4.611 |
MDCK | 0.0000241 |
BBB | 0.927 |
PPB | 0.937383 |
VDSS | 3.134 |
FU | 0.0761377 |
CYP1A2-inh | 0.288 |
CYP1A2-sub | 0.583 |
CYP2c19-inh | 0.285 |
CYP2c19-sub | 0.938 |
CYP2c9-inh | 0.192 |
CYP2c9-sub | 0.753 |
CYP2d6-inh | 0.02 |
CYP2d6-sub | 0.683 |
CYP3a4-inh | 0.028 |
CYP3a4-sub | 0.303 |
CL | 12.283 |
T12 | 0.056 |
hERG | 0.012 |
Ames | 0.009 |
ROA | 0.111 |
SkinSen | 0.126 |
Carcinogencity | 0.061 |
EI | 0.936 |
Respiratory | 0.96 |
NR-Aromatase | 0.036 |
Antiviral | No |
Prediction | 0.733875 |